Leadership Team
Aamir Mahmood
President and CEO
Year of entry: 2024
Born: 1976
Location: USA
Education: BS in Marketing and Management from Oklahoma State University, an MBA from Oklahoma City University, and Executive Education from Harvard Business School
Previous engagements/experience: Aamir has more than twenty years of executive experience in the medical device industry, demonstrating a proven track record in commercial roles within Global cardiovascular device markets. His expertise spans sales, marketing, and strategy functions at organizations such as LivaNova, Boston Scientific, and Merck. Most recently, Aamir served as the General Manager/Vice President, Americas, at MicroPort CRM (MicroPort acquired the organization from LivaNova in 2017), a cardiovascular medical device company with primary focus on cardiac rhythm management, electrophysiology, arrhythmia assessment, and other cardiac devices used for diagnosing, treating, and managing heart rhythm disorders and heart failure. Prior to overseeing the Americas for MicroPort, Aamir rotated through two EXPAT assignments in Europe running Global Sales, followed by Global Marketing and Strategy, including M&A.
Other significant ongoing assignments: Aceco Valves Member, Board of Directors, Biozen Member, Board of Directors, YPO Member
Acarix holdings:
Shares: 10,905,824
Employee Options: 50,000,000
Christian Lindholm
Chief Financial Officer
Year of entry: 2016
Born: 1964
Location: Sweden
Education: Business Administration at the University of Växjö and Kristianstad University.
Previous engagements/experience: For the past 17 years, he has held positions as CFO in both private and listed companies. Prior to joining Acarix, Christian Lindholm was CFO of Doro AB and TFS International AB.
Other significant ongoing assignments: Board Member of Lindholm Finance AB.
Acarix holdings:
Shares: 79,328
Employee Options: 4,000,000
George Chrysant
MD as Chief Medical Advisor
Year of entry: 2024
Location: USA
Education: Medical School (University of Oklahoma)
Previous engagements/experience: Chief Medical Officer for INTEGRIS Cardiovascular Physicians. Board certified in Cardiovascular Diseases, Interventional Cardiology and Cardiac CT. Special interest in complex coronary imaging and physiology as well as cardiac CT and FFRct. Was local PI in both PROMISE and PRECISE trials.
Carma Connely
Head of Operations and Customer Excellence
Year of entry: 2022
Born: 1975
Location: USA
Education: BS in Chemistry from Butler University, IN and MS in Biochemistry from University of Denver, CO.
Previous engagements/experience: Carma has over 20 years of experience in the medical device field with a focus on neurosurgery and cardiology. She has experience in sales, product management, quality, regulatory, operations, clinical education, and finance. Carma previously held roles as Vice President of Operations at Coala Life, Product Management at Raumedic and launched multiple European companies into the US market.
Acarix holdings:
Shares: 408,520
Employee Options: 658,520
Beji George
Head of Global Strategy & Therapy Development
Year of entry: 2025
Born: 1978
Location: USA
Education: B.S. in Kinesiology from the University of Houston, Radiologic Sciences degree from PIMA Medical Institute, Executive MBA from the University of East London – Ducere Global Business School (April 2026)
Previous Engagement/Experience: Beji brings over 25 years of leadership experience in the MedTech industry, with deep expertise in cardiac therapy development and global commercialization. His ability to bridge clinical insight with strategic execution will be a strong driver as we accelerate our global initiatives. Most recently, Beji served as Senior Director of Global Field Operations & Therapy Development at Heart Medical, where he led a pivotal Class III IDE trial. Prior to that, he served as US Leadless Clinical Manager at Abbott Laboratories, spearheading field clinical operations for the launch of Abbott’s first Leadless pacemakers – Aveir VR and DR. He also held the role of Senior Therapy Development Manager at EBR Systems, where he led efforts on the WiSE SOLVE-CRT trial. His career spans additional impactful roles at Boston Scientific and Medtronic, making him uniquely equipped to help shape Acarix’s next phase of growth.
Andrew Turk
Regional Director, Northeast
Year of entry: 2026
Born: 1978
Location: USA
Education: Andrew holds a B.S. in Business Administration from Rider University.
Previous Engagements/Experience: Andrew Turk is a seasoned MedTech commercial leader with over 20 years of experience driving adoption of cardiovascular diagnostics, remote monitoring, and non-invasive clinical technologies. He has led growth initiatives across electrophysiology, ambulatory ECG, virtual care, and enterprise health systems, helping scale innovative platforms from early commercialization through broad clinical adoption. Previously, Andrew held senior sales and leadership roles at Baxter (formerly Bardy Diagnostics), Vector Remote Care, LivaNova/Sorin, St. Jude Medical, and Mednet Healthcare, where he played key roles in launching and expanding remote monitoring and cardiac diagnostic solutions. He is known for bridging clinical insight with disciplined execution and for building durable commercial strategies that accelerate market entry and long-term growth.
Acarix holdings:
Shares: 500,000